Which drugs does patent 6,136,783 protect, and when does it expire?
Patent 6,136,783 protects CANCIDAS and is included in one NDA. There has been one Paragraph IV challenge on Cancidas.
Protection for CANCIDAS has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-nine patent family members in forty countries.
This patent has expired prematurely due to non-payment of maintenance fees. See details below.